Your browser doesn't support javascript.
loading
Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.
Sweiss, Karen; Calip, Gregory Sampang; Holden, Jaime; Lewkowski, Paulina; Mialik, Iryna; Johnson, Jeremy; Galvin, John P; Rondelli, Damiano; Patel, Pritesh.
Affiliation
  • Sweiss K; Department of Pharmacy Practice, College of Pharmacy, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Calip GS; Cancer Center, University of Illinois, Chicago, IL, USA.
  • Holden J; Cancer Center, University of Illinois, Chicago, IL, USA.
  • Lewkowski P; Center for Pharmacoepidemiology and Pharmacoeconomic Research, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Mialik I; Department of Pharmacy Practice, College of Pharmacy, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Johnson J; Department of Pharmacy Practice, College of Pharmacy, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Galvin JP; Department of Pharmacy Practice, College of Pharmacy, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Rondelli D; Department of Pharmacy Practice, College of Pharmacy, 14681University of Illinois at Chicago, Chicago, IL, USA.
  • Patel P; Cancer Center, University of Illinois, Chicago, IL, USA.
J Oncol Pharm Pract ; 27(3): 579-587, 2021 Apr.
Article in En | MEDLINE | ID: mdl-32493164

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Antineoplastic Agents, Alkylating / Stem Cell Transplantation / Melphalan / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Antineoplastic Agents, Alkylating / Stem Cell Transplantation / Melphalan / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom